The Worldwide Allergic Conjunctivitis Industry is Estimated to Reach $2.9 Billion by 2031 - ResearchAndMarkets.com
04 Jan 2023
DUBLIN--(BUSINESS WIRE)--The "Allergic Conjunctivitis Market By Drug Class, By Disease Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.
'Allergic Conjunctivitis Market By Drug Class, By Disease Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031'
The global allergic conjunctivitis market was valued at $1,937.99 million in 2021, and is estimated to reach $2,954.2 million by 2031, growing at a CAGR of 4.28% from 2022 to 2031.
An allergic reaction to things such as pollen, mold, or spores can result in an eye inflammation known as allergic conjunctivitis. The conjunctiva is a membrane that covers the interior of the eyelids and the surface of the eyeball. Allergens can irritate the conjunctiva, especially during the hay fever season. Conjunctivitis due to an allergy is extremely prevalent. It is a response by an individual's body to chemicals that it deems to be potentially dangerous.
Conjunctivitis caused by allergens is one of the most commonly occurring allergies. According to the Asthma and Allergy Foundation of America, allergies run in families and impact 30% of adults and 40% of children. Common signs of allergic conjunctivitis include red, watery, burning, and itchy eyes. It's also possible to have puffy eyes when one first wake up in the morning.
The major factors that drive the growth of the allergic conjunctivitis market are increase in patient population suffering from ocular allergies. According to National Centre of medicine allergic conjunctivitis or conjunctival symptoms are present in 30-71% of patients with allergic rhinitis as many people are suffering from allergic conjunctivitis demand for drugs increases.
In addition, many key market players are focusing on R&D activities to develop new drugs for the treatment of ocular allergies is a key trend of the market, which is expected to fuel the growth in the forecast period.
Furthermore, poor hygienic practices such as touching eyes with unclean hands, using contaminated makeup & lotions causes ocular allergy, which is anticipated to drive the market growth in the near future. Rise in prevalence of sexually transmitted diseases tends to drive the market growth. The most prevalent STIs are chlamydia and gonorrhoea, and both can result in conjunctivitis.
Either directly through sexual fluids like semen or when infected individuals rub their eyes after contacting infected genital areas, which are the two ways the illness enters the eye. Thus, such high number of cases are expected to boost the allergic conjunctivitis procedures.
However, unfavorable reimbursements scenarios and lack of awareness of ocular allergies are expected to hinder the growth of the market. Conversely, rapid rise in urbanization leads to more exposure to chemicals and pollutants in both developed and developing countries, which is expected to provide a great opportunity for the investors to invest in the market.
Key Benefits
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the allergic conjunctivitis market analysis from 2021 to 2031 to identify the prevailing allergic conjunctivitis market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the allergic conjunctivitis market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global allergic conjunctivitis market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Drug Class
Antihistamines Mast Cell Stabilizers
Corticosteroids
Others
By Disease Type
By Distribution Channel
Drug stores Retail Pharmacies
Online providers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Akron Operating Company LLC
Grevis Pharmaceutical Private Limited
JAWA Pharmaceuticals Pvt. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/13q0ty
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.